Cor Vasa 2026, 68(4):470-477 | DOI: 10.33678/cor.2026.064

Katetrizační léčba srdečního selhání.

Jan Naar
Kardiologická klinika, 1. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Motol a Homolka, pracoviště Homolka, Praha, Česká republika

A number of non-pharmacological approaches that affect various pathophysiological mechanisms of heart failure are being clinically tested. These methods are at different stages of development. This article focuses on catheter-based techniques for the treatment of heart failure, especially catheter-based left ventricular remodeling and interatrial communication. Regarding catheter-based left ventricular remodeling, some systems have shown promising results in carefully selected patients when performed by an experienced team. Interatrial communication also appears to be effective in certain subgroups of patients with heart failure, both with preserved and reduced left ventricular ejection fraction. © 2026, ČKS.

Keywords: Interatrial communication, Interatrial shunt, Pulmonary artery reduction, Transcatheter left ventricular, remodeling

Received: July 1, 2026; Revised: July 1, 2026; Accepted: July 13, 2026; Prepublished online: August 3, 2026; Published: August 31, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Naar J. Katetrizační léčba srdečního selhání. Cor Vasa. 2026;68(4):470-477. doi: 10.33678/cor.2026.064.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kramer CM, Magovern JA, Rogers WJ, et. al. Reverse remodeling and improved regional function after repair of left ventricular aneurysm. J Thorac Cardiovasc Surg 2002;123:700- Go to original source... Go to PubMed...
    2. Dor V, Saab M, Coste P, et al. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg 1989;37:11-19. Go to original source...
    3. Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009;360:1705-1717. Go to original source... Go to PubMed...
    4. Michler RE, Rouleau JL, Al-Khalidi HR, et al. Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg 2013;146:1139-1145. Go to original source...
    5. Oh JK, Velazquez EJ, Menicanti L, et al. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J 2013;34:39-47. Go to original source... Go to PubMed...
    6. ten Brinke EA, Klautz RJ, Tulner SA, et al. Long-term effects of surgical ventricular restoration with additional restrictive mitral annuloplasty and/or coronary artery bypass grafting on left ventricular function: six-month follow-up by pressurevolume loops. J Thorac Cardiovasc Surg 2010;140:1338-1344. Go to original source... Go to PubMed...
    7. Dor V, Civaia F, Alexandrescu C, et al. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 2011;141:905-916, 916.e1-916.e4. Go to original source... Go to PubMed...
    8. Witkowski TG, ten Brinke EA, Delgado V, et al. Surgical ventricular restoration for patients with ischemic heart failure: determinants of two-year survival. Ann Thorac Surg 2011;91:491-498. Go to original source... Go to PubMed...
    9. Skelley NW, Allen JG, Arnaoutakis GJ, et al. The impact of volume reduction on early and long-term outcomes in surgical ventricular restoration for severe heart failure. Ann Thorac Surg 2011;91:104-111; discussion 111-112. Go to original source...
    10. Starling RC, Jessup M, Oh JK, et al. Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial. Ann Thorac Surg 2007;84:1236-1242. Go to original source... Go to PubMed...
    11. Costanzo MR, Ivanhoe RJ, Kao A, et al. Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial. J Card Fail 2012;18:446-458. Go to original source... Go to PubMed...
    12. Costa MA, Mazzaferri EL Jr, Sievert H, et al. Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study. Circ Heart Fail 2014;7:752- Go to original source... Go to PubMed...
    13. Neužil P, Naar J. Nové technologie v kardiologii. Praha: EEZY Publishing, 2024.
    14. Klein P, Anker SD, Wechsler A, et al. Less invasive ventricular reconstruction for ischaemic heart failure. Eur J Heart Fail 2019;21:1638-1650. Go to original source... Go to PubMed...
    15. Naar J, Skalský I, Krűger A, et al. Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy. J Cardiovasc Transl Res 2021;14:1043-1050. Go to original source...
    16. Estep JD, Ben-Yehuda O, Wechsler AS, et al. Transcatheter Left Ventricular Reconstruction in Heart Failure Patients With Prior Anterior Myocardial Infarction: The Prospective ALIVE Trial. JACC Heart Fail 2025;13:296-308. Go to original source... Go to PubMed...
    17. Anker SD, Starling RC, Khan MS, et al. Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement. JACC Heart Fail 2021;9:453-462. Go to original source... Go to PubMed...
    18. Witte KK, Lipiecki J, Siminiak T, et al. The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation. JACC Heart Fail 2019;7:945-955. Go to original source... Go to PubMed...
    19. ANCORA HEART, Inc. Ancora Heart - Heart Failure Treatment Options and Clinical Trials. Online. Dostupné z: https://www. ancoraheart.com/. [citováno 2026-08-02].
    20. Hamid N, Jorde UP, Reisman M, et al. Transcatheter Left Ventricular Restoration in Patients With Heart Failure. J Card Fail 2023;29:1046-1055. Go to original source... Go to PubMed...
    21. Kurlianskaya A, Chuang ML, Polonetsky O, et. al. Reverse Remodeling Induced by Transcatheter Left Ventricular Restoration System Is Sustained Through 2 Years of Follow-Up. Struct Heart 2025;9:100694. Go to original source...
    22. CARDIAC SUCCESS Ltd. Cardiac Success - Transcatheter Ventricular Repair Device for Heart Failure (Vsling). Online. Dostupné z: https://cardiac success.com/ [citováno 2026-08-02].
    23. Stone GW, Sievert H, Virmani R, et al. Description, Feasibility, and Histological Assessment of the Vsling, a Novel Transcatheter Ventricular Repair Device. Struct Heart 2022;6:100075. Go to original source... Go to PubMed...
    24. Bruckheimer E, Rackauskas G, Verheye S, et al. Transcatheter Pulmonary Artery Banding for HFrEF: Initial Results: Exercise Hemodynamics From the Ongoing First-in-Human Trial. JACC Basic Transl Sci 2024;9:445-447. Go to original source... Go to PubMed...
    25. Lutembacher R. De la sténose mitrale avec communication interauriculaire. Arch Mal Coeur 1916;9:237-260.
    26. Malek F, Neuzil P, Gustafsson F, et al. Clinical outcome of transcatheter treatment of heart failure with preserved or J. Naar477 mildly reduced ejection fraction using a novel implant. Int J Cardiol 2015;187:227-228. Go to original source... Go to PubMed...
    27. Hasenfuß G, Hayward C, Burkhoff D, et al. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet 2016;387:1298-1304. Go to original source... Go to PubMed...
    28. Feldman T, Mauri L, Kahwash R, et al. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation 2018;137:364- Go to original source... Go to PubMed...
    29. Shah SJ, Borlaug BA, Chung ES, et al. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet 2022;399:1130-1140. Go to original source... Go to PubMed...
    30. Gustafsson F, Petrie MC, Komtebedde J, et al. 2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II. JACC Heart Fail 2024;12:1425-1438. Go to original source... Go to PubMed...
    31. Stone GW, Lindenfeld J, Rodés-Cabau J, et al. Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial. Circulation 2024;150:1931-1943. Go to original source...
    32. Jagadeesan V, Gray WA, Shah SJ, et al. Atrial shunt therapy for heart failure: an update. J Soc Cardiovasc Angiogr Interv 2023;2(6Part B):101203. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content